- Home
- ALEC vs QD Comparison
ALEC vs QD Comparison
Compare ALEC & QD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- QD
- Stock Information
- Founded
- ALEC 2013
- QD 2014
- Country
- ALEC United States
- QD China
- Employees
- ALEC N/A
- QD N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- QD Finance: Consumer Services
- Sector
- ALEC Health Care
- QD Finance
- Exchange
- ALEC Nasdaq
- QD Nasdaq
- Market Cap
- ALEC 454.5M
- QD 433.7M
- IPO Year
- ALEC 2019
- QD 2017
- Fundamental
- Price
- ALEC $3.76
- QD $2.46
- Analyst Decision
- ALEC Strong Buy
- QD
- Analyst Count
- ALEC 5
- QD 0
- Target Price
- ALEC $20.67
- QD N/A
- AVG Volume (30 Days)
- ALEC 749.0K
- QD 491.2K
- Earning Date
- ALEC 11-06-2024
- QD 12-09-2024
- Dividend Yield
- ALEC N/A
- QD N/A
- EPS Growth
- ALEC N/A
- QD N/A
- EPS
- ALEC N/A
- QD N/A
- Revenue
- ALEC $61,508,000.00
- QD $27,875,484.00
- Revenue This Year
- ALEC N/A
- QD N/A
- Revenue Next Year
- ALEC $118.87
- QD N/A
- P/E Ratio
- ALEC N/A
- QD N/A
- Revenue Growth
- ALEC N/A
- QD N/A
- 52 Week Low
- ALEC $3.49
- QD $1.52
- 52 Week High
- ALEC $8.90
- QD $2.60
- Technical
- Relative Strength Index (RSI)
- ALEC 35.09
- QD 61.91
- Support Level
- ALEC $3.57
- QD $2.27
- Resistance Level
- ALEC $6.14
- QD $2.50
- Average True Range (ATR)
- ALEC 0.48
- QD 0.09
- MACD
- ALEC -0.20
- QD -0.00
- Stochastic Oscillator
- ALEC 10.19
- QD 95.65
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About QD Qudian Inc. each representing one
Qudian Inc is a consumer-oriented technology company engaged in the operation of online platforms to provide small consumer credit products in the People's Republic of China. It aims to empower financial institutions with its technological capabilities, help them improve marketing and operating efficiency, and enable financial institutions to efficiently connect their diversified financial products with scene traffic across the entire network It derives a majority of its revenue from the People's Republic of China.